Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Exomic sequencing of four rare central nervous system tumor types.

Bettegowda C, Agrawal N, Jiao Y, Wang Y, Wood LD, Rodriguez FJ, Hruban RH, Gallia GL, Binder ZA, Riggins CJ, Salmasi V, Riggins GJ, Reitman ZJ, Rasheed A, Keir S, Shinjo S, Marie S, McLendon R, Jallo G, Vogelstein B, Bigner D, Yan H, Kinzler KW, Papadopoulos N.

Oncotarget. 2013 Apr;4(4):572-83.

2.

Cytogenetic analysis of 109 pediatric central nervous system tumors.

Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K.

Cancer Genet Cytogenet. 1993 Nov;71(1):40-9.

PMID:
8275451
3.

Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.

Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP.

Neurosurgery. 1995 Oct;37(4):764-73.

PMID:
8559307
4.

Mutation analysis of gene PAX6 in human gliomas.

Pinto GR, Clara CA, Santos MJ, Almeida JR, Burbano RR, Rey JA, Casartelli C.

Genet Mol Res. 2007 Oct 5;6(4):1019-25.

5.

Genetics of nervous system tumors.

Shapiro JR.

Hematol Oncol Clin North Am. 2001 Dec;15(6):961-77. Review.

PMID:
11770302
6.

Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.

von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH.

Genes Chromosomes Cancer. 1996 Sep;17(1):37-44.

PMID:
8889505
7.

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A.

Acta Neuropathol. 2011 Mar;121(3):397-405. doi: 10.1007/s00401-011-0802-6. Epub 2011 Jan 29.

PMID:
21274720
8.

SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups.

Kleinschmidt-DeMasters BK, Donson AM, Richmond AM, Pekmezci M, Tihan T, Foreman NK.

J Neuropathol Exp Neurol. 2016 Apr;75(4):295-8. doi: 10.1093/jnen/nlw010. Epub 2016 Mar 4.

PMID:
26945037
9.

Chromosome abnormalities in low-grade central nervous system tumors.

Griffin CA, Long PP, Carson BS, Brem H.

Cancer Genet Cytogenet. 1992 May;60(1):67-73.

PMID:
1591709
10.

Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.

Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B, Roggendorf W.

Acta Neuropathol. 2007 Mar;113(3):325-37. Epub 2007 Jan 31.

PMID:
17265049
11.

H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?

Gessi M, Gielen GH, Hammes J, Dörner E, Mühlen AZ, Waha A, Pietsch T.

J Neurooncol. 2013 Mar;112(1):67-72. doi: 10.1007/s11060-012-1040-z. Epub 2013 Jan 26.

PMID:
23354654
12.

Pediatric brain tumors: loss of heterozygosity at 17p and TP53 gene mutations.

Orellana C, Hernandez-Martí M, Martínez F, Castel V, Millán JM, Alvarez-Garijo JA, Prieto F, Badía L.

Cancer Genet Cytogenet. 1998 Apr 15;102(2):93-9.

PMID:
9546059
13.

Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients.

Szybka M, Bartkowiak J, Zakrzewski K, Polis L, Liberski P, Kordek R.

Clin Neuropathol. 2003 Jul-Aug;22(4):180-6.

PMID:
12908754
14.

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, Batchelor TT, Ligon KL, Iafrate AJ, Ligon AH, Louis DN, Santagata S.

PLoS One. 2011 Mar 29;6(3):e17948. doi: 10.1371/journal.pone.0017948.

15.

Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.

Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A.

Am J Pathol. 1999 Aug;155(2):627-32.

16.

BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.

Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL.

J Surg Oncol. 2015 Mar;111(3):359-64. doi: 10.1002/jso.23822. Epub 2014 Oct 24.

PMID:
25346165
17.

The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.

Cykowski MD, Allen RA, Kanaly AC, Fung KM, Marshall R, Perry A, Stolzenberg ED, Dunn ST.

J Neurooncol. 2013 Dec;115(3):477-86. doi: 10.1007/s11060-013-1249-5. Epub 2013 Sep 21.

PMID:
24057326
18.

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

Capper D, Weissert S, Balss J, Habel A, Meyer J, Jäger D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A.

Brain Pathol. 2010 Jan;20(1):245-54. doi: 10.1111/j.1750-3639.2009.00352.x. Epub 2009 Oct 27.

PMID:
19903171
19.

Aberrant CpG island methylation of multiple genes in ependymal tumors.

Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, de Campos JM, Gutierrez M, Rey JA.

J Neurooncol. 2004 Mar-Apr;67(1-2):159-65.

PMID:
15072463
20.

Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy.

Zhang JG, Kruse CA, Driggers L, Hoa N, Wisoff J, Allen JC, Zagzag D, Newcomb EW, Jadus MR.

J Neurooncol. 2008 May;88(1):65-76. doi: 10.1007/s11060-008-9534-4. Epub 2008 Feb 8.

Items per page

Supplemental Content

Write to the Help Desk